November 11, 2008
ProteoTech to Present at Rodman & Renshaw's 10th Annual Healthcare Conference

 

August 07, 2008
ProteoTech's Exebryl-1^® Enters Human Clinical Trials for the Treatment of Alzheimer's Disease

 

July 29, 2008
Exebryl-1^® Phase I Human Clinical Trial for Alzheimer's disease commences

 

July 25, 2008
ProteoTech to present at International Alzheimer's Conference—Chicago, IL.

 

May 28, 2008
ProteoTech receives clearance from FDA to proceed with Phase I Human Clinical Trials for Exebryl-1^®

 

May 15, 2008
ProteoTech receives NIH SBIR Phase II continuation award for systemic amyloidosis therapeutic research

 

April 28, 2008
ProteoTech files IND for Exebryl-1^® for the treatment of mild-to-moderate Alzheimer's Disease